WallStreetZenWallStreetZen

NASDAQ: ADPT
Adaptive Biotechnologies Corp Stock Ownership - Who owns Adaptive Biotechnologies?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Adaptive Biotechnologies Corp insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Peter M. NeupertDirector2024-03-1215,000$0.84
$12.60kBuy
Sharon BenzenoChief Commercial Ofc Imm Med2024-03-0510,746$3.43
$36.86kSell
Susan BobulskyChief Commercial Officer MRD2024-03-056,975$3.44
$23.99kSell
Susan BobulskyChief Commercial Officer MRD2024-03-056,016$3.43
$20.63kSell
Francis LoChief People Officer2024-03-051,813$3.44
$6.24kSell
Francis LoChief People Officer2024-03-0512,887$3.43
$44.20kSell
Sharon BenzenoChief Commercial Ofc Imm Med2024-03-0518,644$3.44
$64.14kSell
Tycho PetersonChief Financial Officer2024-03-0515,456$3.44
$53.17kSell
Kyle PiskelPrincipal Accounting Officer2024-03-057,727$3.43
$26.50kSell
Chad M. RobinsCEO and Chairman2024-03-0542,794$3.43
$146.78kSell

1 of 3

ADPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADPT insiders and whales buy or sell their stock.

ADPT Shareholders

What type of owners hold Adaptive Biotechnologies Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Viking Global Performance LLC21.36%30,993,708$75.62MInsider
Viking Global Investors LP20.67%29,993,708$73.18MInsider
Viking Global Investors LP20.67%29,993,708$73.18MInstitution
Ark Investment Management LLC8.83%12,806,513$31.25MInstitution
Vanguard Group Inc8.80%12,767,684$31.15MInstitution
David E. Goel8.48%12,310,594$30.04MInsider
Matrix Capital Management Company LP7.98%11,572,590$28.24MInstitution
Blackrock Inc7.87%11,421,554$27.87MInstitution
Nikko Asset Management Americas Inc4.49%6,511,659$15.89MInstitution
Sumitomo Mitsui Trust Holdings Inc4.49%6,511,659$15.89MInstitution

1 of 3

ADPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADPT62.07%37.93%Net SellingNet Selling
OCGN10.16%11.93%Net Selling
TNYA55.16%44.84%Net BuyingNet Buying
RVNC73.75%26.25%Net SellingNet Selling
TCRX66.65%29.73%Net Buying
View Top Biotech Stocks

Adaptive Biotechnologies Stock Ownership FAQ

Who owns Adaptive Biotechnologies?

Adaptive Biotechnologies (NASDAQ: ADPT) is owned by 98.97% institutional shareholders, 60.47% Adaptive Biotechnologies insiders, and 0.00% retail investors. Viking Global Performance LLC is the largest individual Adaptive Biotechnologies shareholder, owning 30.99M shares representing 21.36% of the company. Viking Global Performance LLC's Adaptive Biotechnologies shares are currently valued at $72.37M.

If you're new to stock investing, here's how to buy Adaptive Biotechnologies stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.